Cargando…
Rho GTPases as therapeutic targets in Alzheimer’s disease
The progress we have made in understanding Alzheimer’s disease (AD) pathogenesis has led to the identification of several novel pathways and potential therapeutic targets. Rho GTPases have been implicated as critical components in AD pathogenesis, but their various functions and interactions make un...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732365/ https://www.ncbi.nlm.nih.gov/pubmed/29246246 http://dx.doi.org/10.1186/s13195-017-0320-4 |